Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -20,252 | -16,291 | -2,467 | -6,830 |
| Depreciation Amortization | 3 | 1 | N/A | 1 |
| Accounts payable and accrued liabilities | 597 | 811 | 1,118 | N/A |
| Other Working Capital | 624 | 781 | 826 | 210 |
| Other Operating Activity | 599 | -234 | -947 | 3,049 |
| Operating Cash Flow | $-18,429 | $-14,932 | $-1,470 | $-3,570 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -10,003 | N/A | N/A | N/A |
| PPE Investments | -39 | -12 | N/A | -2 |
| Other Investing Activity | -75 | 0 | 0 | 0 |
| Investing Cash Flow | $-10,117 | $-12 | $N/A | $-2 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 165 | 39 | 24 | N/A |
| Other Financing Activity | 58,507 | 58,556 | 2,524 | 4,680 |
| Financing Cash Flow | $58,672 | $58,595 | $2,548 | $4,680 |
| Beginning Cash Position | 2,429 | 2,429 | 2,429 | 1,310 |
| End Cash Position | 32,555 | 46,080 | 3,507 | 2,420 |
| Net Cash Flow | $30,126 | $43,651 | $1,078 | $1,110 |
| Free Cash Flow | ||||
| Operating Cash Flow | -18,429 | -14,932 | -1,470 | -3,570 |
| Capital Expenditure | -39 | -12 | N/A | N/A |
| Free Cash Flow | -18,468 | -14,944 | -1,470 | -3,570 |